查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1870009

抗凝血酶市场规模、份额和趋势分析报告：按应用、原材料、类型、地区和细分市场预测（2025-2033 年）

Antithrombin Market Size, Share & Trends Analysis Report By Application (Therapeutics, Diagnostics), By Source (Human, Recombinant Goat Milk), By Type, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

抗凝血酶市场摘要

2024年全球抗凝血酶市场规模估计为6.584亿美元，预计2033年将达到9.972亿美元。

预计从 2025 年到 2033 年，该市场将以 4.7% 的复合年增长率成长。凝血障碍（如深层静脉栓塞症、肺动脉栓塞和遗传性抗凝血酶缺乏症）的日益普遍是推动抗凝血酶市场成长的主要因素。

手术量增加、创伤病例增加以及妊娠併发症上升，都会增加血栓症的风险，这也导致了抗凝血酶治疗需求的增长。抗凝血酶产业的发展动力源于血栓性栓塞症和凝血障碍病例的持续增加、人们对遗传性抗凝血酶缺乏症认识的提高以及早期抗凝血治疗重要性的认识。在美国，每年约有90万人患有静脉血栓栓塞症（VTE），其中住院期间及出院后不久的患者、接受癌症治疗的患者以及孕妇的风险尤其高。据估计，每年有6万至10万美国人死于VTE，还有更多人遭受长期併发症。这种情况凸显了有效预防和治疗的紧迫性。

外科手术、创伤和妊娠併发症的增加进一步推动了抗凝血酶治疗的需求。全球可用的治疗方案包括血浆衍生产品和重组产品，其中重组产品因其安全性高、纯度高和感染风险低而广泛使用。在生物技术进步和监管核准的推动下，抗凝血酶在加护治疗、心臟外科手术和产科领域的应用不断扩展，持续推动全球抗凝血酶市场的发展。

目录

第一章调查方法和范围

第二章执行摘要

第三章 抗凝血酶市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 抗凝血酶市场分析工具
    • 产业分析—波特五力分析
    • PESTEL 分析

第四章 抗凝血酶市场：应用预测与趋势分析

  • 使用细分仪表板
  • 抗凝血酶市场：按应用领域分析变化
  • 全球抗凝血酶市场规模及趋势分析（按应用领域划分，2021-2033 年）
    • 治疗
    • 诊断
    • 研究
    • 其他的

第五章：抗凝血酶市场：依原料分類的估算与趋势分析

  • 原料细分仪表板
  • 抗凝血酶市场：依原料分類的波动分析
  • 全球抗凝血酶市场规模及趋势分析（2021-2033）
    • 人类
    • 改良山羊奶
    • 其他的

第六章：抗凝血酶市场：按类型分類的估算与趋势分析

  • 类型细分仪表板
  • 抗凝血酶市场：按类型分類的差异分析
  • 全球抗凝血酶市场规模及趋势分析（按类型划分）（2021-2033 年）
    • 抗凝血剂
    • 抗血小板药物
    • 溶栓药物

第七章：抗凝血酶市场：区域估算与趋势分析

  • 区域市场概览
  • 2024 年及 2030 年区域市占率分析
  • 按地区分類的抗凝血酶市场：主要结论
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 丹麦
    • 挪威
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商概况
  • 公司简介
    • CSL
    • Grifols, SA
    • Takeda Pharmaceutical Company Limited.
    • Octapharma AG
    • LFB
    • ENDPOINT HEALTH, INC.
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
    • Medix Biochemica
Product Code: GVR-4-68040-781-8

Antithrombin Market Summary

The global antithrombin market size was estimated at USD 658.4 million in 2024 and is projected to reach USD 997.2 million by 2033, growing at a CAGR of 4.7% from 2025 to 2033. The rising prevalence of coagulation disorders such as deep vein thrombosis, pulmonary embolism, and hereditary antithrombin deficiency primarily drives the antithrombin market.

Increasing surgical procedures, trauma cases, and complications during pregnancy that elevate thrombosis risk are also contributing to higher demand for antithrombin therapy. The antithrombin industry is driven by the steady rise of thromboembolic and coagulation disorders, growing awareness of hereditary antithrombin deficiency, and the importance of early anticoagulant therapy. In the U.S, 900,000 people are affected by venous thromboembolism (VTE) each year, with individuals at particularly high risk during or just after hospitalization, cancer treatment, or pregnancy. An estimated 60,000 to 100,000 Americans die annually from VTE, while many others experience long-term complications, thus highlighting the critical need for effective prevention and management.

Increasing surgical procedures, trauma incidents, and pregnancy-related complications have further amplified the demand for antithrombin therapy. Treatment options worldwide include plasma-derived and recombinant formulations, with recombinant products gaining wider acceptance due to higher safety, purity, and reduced infection risks. The expansion of their use in critical care, cardiac surgeries, and obstetric cases, supported by advancements in biotechnology and favorable regulatory approvals, continues to propel the global antithrombin market forward.

Global Antithrombin Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global antithrombin market report based on application, source, type, and region:

  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Therapeutics
  • Diagnostics
  • Research
  • Other
  • Source Outlook (Revenue, USD Million, 2021 - 2033)
  • Human
  • Recombinant Goat Milk
  • Others
  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Anticoagulant
  • Antiplatelet
  • Thrombolytic Drugs
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Source
    • 1.2.3. Type
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Source
  • 1.9. List of Primary Source
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. Source outlook
    • 2.2.3. Type outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Antithrombin Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Antithrombin Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Antithrombin Market: Application Estimates & Trend Analysis

  • 4.1. Application Segment Dashboard
  • 4.2. Antithrombin Market: Application Movement Analysis
  • 4.3. Global Antithrombin Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
    • 4.3.1. Therapeutics
      • 4.3.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.3.2. Diagnostics
      • 4.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.3.3. Research
      • 4.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.3.4. Other
      • 4.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Antithrombin Market: Source Estimates & Trend Analysis

  • 5.1. Source Segment Dashboard
  • 5.2. Antithrombin Market: Source Movement Analysis
  • 5.3. Global Antithrombin Market Size & Trend Analysis, by Source, 2021 to 2033 (USD Million)
    • 5.3.1. Human
      • 5.3.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.3.2. Recombinant Goat Milk
      • 5.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.3.3. Others
      • 5.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Antithrombin Market: Type Estimates & Trend Analysis

  • 6.1. Type Segment Dashboard
  • 6.2. Antithrombin Market: Type Movement Analysis
  • 6.3. Global Antithrombin Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
    • 6.3.1. Anticoagulant
      • 6.3.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.3.2. Antiplatelet
      • 6.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.3.3. Thrombolytic Drugs
      • 6.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Antithrombin Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2024 & 2030
  • 7.3. Antithrombin Market by Region: Key Takeaways
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.6. Sweden
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework/ reimbursement structure
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.8. Norway
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework/ reimbursement structure
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. China
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. India
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. Japan
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework/ reimbursement structure
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework/ reimbursement structure
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key company heat map analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. CSL
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Grifols, S.A.
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Takeda Pharmaceutical Company Limited.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Octapharma AG
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. LFB
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. ENDPOINT HEALTH, INC.
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Siemens Healthineers AG
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Thermo Fisher Scientific Inc.
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Medix Biochemica
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global antithrombin market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 4 Global antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 5 Global antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 6 North America antithrombin market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 8 North America antithrombin market, by sources, 2021 - 2033 (USD Million)
  • Table 9 North America antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 10 U.S. antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 11 U.S. antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 12 U.S. antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 13 Canada antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 14 Canada antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 15 Canada antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 16 Mexico antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 17 Mexico antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 18 Mexico antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 19 Europe antithrombin market, by country, 2021 - 2033 (USD Million)
  • Table 20 Europe antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 21 Europe antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 22 Europe antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 23 Germany antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 24 Germany antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 25 Germany antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 26 UK antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 27 UK antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 28 UK antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 29 France antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 30 France antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 31 France antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 32 Italy antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 33 Italy antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 34 Italy antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 35 Spain antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 36 Spain antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 37 Spain antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 38 Sweden antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 39 Sweden antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 40 Sweden antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 41 Denmark antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 42 Denmark antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 43 Denmark antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 44 Norway antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 45 Norway antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 46 Norway antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific antithrombin market, by country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 51 China antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 52 China antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 53 China antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 54 India antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 55 India antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 56 India antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 57 Japan antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 58 Japan antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 59 Japan antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 60 Australia antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 61 Australia antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 62 Australia antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 63 South Korea antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 64 South Korea antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 65 South Korea antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 66 Thailand antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 67 Thailand antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 68 Thailand antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 69 Latin America antithrombin market, by country, 2021 - 2033 (USD Million)
  • Table 70 Latin America antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 71 Latin America antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 72 Latin America antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 73 Brazil antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 74 Brazil antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 75 Brazil antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 76 Argentina antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 77 Argentina antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 78 Argentina antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 79 Middle East & Africa antithrombin market, by country, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 83 South Africa antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 84 South Africa antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 85 South Africa antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 89 UAE antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 90 UAE antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 91 UAE antithrombin market, by type, 2021 - 2033 (USD Million)
  • Table 92 Kuwait antithrombin market, by application, 2021 - 2033 (USD Million)
  • Table 93 Kuwait antithrombin market, by source, 2021 - 2033 (USD Million)
  • Table 94 Kuwait antithrombin market, by type, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market snapshot
  • Fig. 8 Antithrombin market segmentation
  • Fig. 9 Market Snapshot
  • Fig. 10 Therapeutic approach and disease outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 Antithrombin market dynamics
  • Fig. 13 Antithrombin market: Porter's five forces analysis
  • Fig. 14 Antithrombin market: PESTLE analysis
  • Fig. 15 Application market, 2021 - 2033 (USD Million)
  • Fig. 16 Therapeutics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 17 Diagnostic market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 18 Research market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 19 Other market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 20 Source market, 2021 - 2033 (USD Million)
  • Fig. 21 Human market estimates and forecast, 2021 - 2033
  • Fig. 22 Recombinant goat milk market estimates and forecast, 2021 - 2033
  • Fig. 23 Others market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Type market, 2021 - 2033 (USD Million)
  • Fig. 25 Anticoagulant market, 2021 - 2033 (USD Million)
  • Fig. 26 Antiplatelet market, 2021 - 2033 (USD Million)
  • Fig. 27 Thrombolytic drugs market, 2021 - 2033 (USD Million)
  • Fig. 28 Antithrombin market revenue, by region
  • Fig. 29 Regional marketplace: Key takeaways
  • Fig. 30 North America antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 31 U.S. country dynamics
  • Fig. 32 U.S. antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 33 Canada country dynamics
  • Fig. 34 Canada antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 35 Mexico country dynamics
  • Fig. 36 Mexico antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 37 Europe antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 38 UK country dynamics
  • Fig. 39 UK antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 40 Germany country dynamics
  • Fig. 41 Germany antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 42 France country dynamics
  • Fig. 43 France antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 44 Italy country dynamics
  • Fig. 45 Italy antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 46 Spain country dynamics
  • Fig. 47 Spain antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 48 Sweden country dynamics
  • Fig. 49 Sweden antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 50 Denmark country dynamics
  • Fig. 51 Denmark antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 52 Norway country dynamics
  • Fig. 53 Norway antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 54 Asia Pacific antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 55 China country dynamics
  • Fig. 56 China antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 57 India country dynamics
  • Fig. 58 India antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 59 Japan country dynamics
  • Fig. 60 Japan antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 61 Australia country dynamics
  • Fig. 62 Australia antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 63 South Korea country dynamics
  • Fig. 64 South Korea antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 65 Thailand country dynamics
  • Fig. 66 Thailand antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 67 Latin America antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 68 Brazil country dynamics
  • Fig. 69 Brazil antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 70 Argentina country dynamics
  • Fig. 71 Argentina antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 72 MEA antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 73 South Africa country dynamics
  • Fig. 74 South Africa antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 75 Saudi Arabia country dynamics
  • Fig. 76 Saudi Arabia antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 77 UAE country dynamics
  • Fig. 78 UAE antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 79 Kuwait country dynamics
  • Fig. 80 Kuwait antithrombin market, 2021 - 2033 (USD Million)
  • Fig. 81 Company categorization
  • Fig. 82 Company market position analysis
  • Fig. 83 Strategic framework